2020 Volume 45 Issue 1 Pages 95-96
We report 38 patients with 42 skin defects who were treated with TERUDERMIS. The affected regions included fingers and toes in 81.0% and 11.9% of cases, respectively. Complications included fractures and nail bed defects in 35.7% and 31.0% of cases, respectively. Severe skin defects were seen in more than half of the cases, while a single mild skin defect was observed in 45.2% of cases. Skin graft surgery was performed in 26.2% of cases, whereas 71.4% of cases, that is, the majority, showed healing without receiving skin graft. TERUDERMIS enhances the healing mechanism in wound regions, and is of clinical significance in that it allows safe and easy wound management.